fg-4592 has been researched along with Anemia--Refractory* in 1 studies
1 other study(ies) available for fg-4592 and Anemia--Refractory
| Article | Year |
|---|---|
Successful treatment of anti-EPO antibody associated refractory anemia with hypoxia-inducible factor prolyl hydroxylase inhibitor.
Topics: Anemia, Refractory; Autoantibodies; Bone Marrow; Erythropoietin; Female; Glycine; Humans; Hypoxia-Inducible Factor-Proline Dioxygenases; Isoquinolines; Middle Aged; Renal Insufficiency, Chronic; Treatment Outcome | 2020 |